By generating a specific mutation in lab mice, researchers determined that a protein domain in an enzyme called adenosine deaminase 1 p150 is necessary for binding and editing certain RNA molecules. Mutant mice showed inhibited growth after birth, as well as abnormally developed organs. Interestingly, their brains showed characteristics similar to encephalopathy seen in humans suffering from Aicardi-Goutières syndrome (AGS), a genetic inflammatory disorder. This work could help revolutionize treatment methods for AGS.
from Top Health News -- ScienceDaily https://ift.tt/3Ckha2a
Subscribe to:
Post Comments (Atom)
Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO
However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...
-
The IT major further said the Ebit margin for the current quarter is expected to be between 20.5-21 per cent from Home Page https://ift.tt...
-
New heat-harnessing 'solar' cells that reflect 99% of the energy they can't convert to electricity could help bring down the pri...
-
Researchers have combined embryonic cells and liver cells in a new cell culture test. This combination lets them detect adverse effects that...
No comments:
Post a Comment